VIH/SIDA en embarazadas: evaluación hematológica e inmunológica y peso de sus neonatos

Objective: To determine the incidence of infection by human immunodeficiency virus and the effects on the weight of the newborn, in pregnant women who attend the University Hospital of Caracas. Methods: Seropositive pregnant women for human immunodeficiency virus infection were included. Elisa was performed for human immunodeficiency virus infection, Websternblot, hematology and chemistry, CD3, CD4 and CD8 lymphocytes by cytometry, viral load, the weight of 204 neonates and the treatment scheme received were recorded. Results: The frequency of infection by human immunodeficiency virus in pregnant women has increased since the year 2000; most occur during the third trimester. 68.55% of pregnant women in the second and third trimester had hemoglobin greater than 11 g and 31.45% had hemoglobin between 7 and 10 g. The CD4/CD8 ratio was decreased. Second trimester CD4 counts were lowest in patients with hemoglobin between 7 and 10 grams. This relationship was not seen in the third trimester, perhaps because of the degree of viral suppression by treatment; mothers of 95.7% of low birth weight infants received combination antiretroviral therapy, there were no low birth weight infants born to mothers who received monotherapy. Conclusion: The prevalence of human immunodeficiency virus infection was 1.6%. The prevalence of anemia was 31.45%. The CD4/CD8 ratio was decreased. There were 11.3% of neonates with low birth weight, in 95.7% the mothers received combination antiretroviral therapy.